Autopsy report · NCT03069989

Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Sufficient information was gathered from cohort 1 to terminate the study without proceeding to optional cohort 2.”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 months before it started.
Ran for about 1 year 1 month before it stopped.
8 participants enrolled.
Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: GlaxoSmithKline
Sponsor type: Industry
Conditions: Idiopathic Pulmonary Fibrosis
Interventions: GSK3008348; Placebo; [18F]-FBA-A20FMDV2
Participants: 8
Sites: 3
Countries: United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.